• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Preventive Cardiology: Companion to Braunwald's Heart Disease

Preventive Cardiology: Companion to Braunwald's Heart Disease

Expert Consult - Online and Print

9781437713664
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 30 DAYS
700,51 zł
595,43 zł Zniżka 105,08 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 595,43 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis

Preventive Cardiology-a new Companion to Braunwalds Heart Disease-addresses the prevention and risk stratification of cardiovascular disease so that you can delay the onset of disease and moderate the effects and complications. Drs. Roger Blumenthal, JoAnne Foody, and Nathan Wong discuss the full range of relevant considerations, including the epidemiology of heart disease, risk assessment, risk factors, multiple risk factor-based prevention strategies, and developments in genetics and personalized medicine. With access to the fully searchable text online at www.expertconsult.com, this authoritative reference gives you the clinically relevant information you need for the effective prevention of cardiovascular disease.

Szczegóły produktu
Saunders
48578
9781437713664
9781437713664

Opis

Rok wydania
2011
Numer wydania
1
Oprawa
twarda
Liczba stron
632
Wymiary (mm)
222 x 281
Waga (g)
1940
  • Contents

    1. Preventive Cardiology: Past, Present and Future

    2. National and International Trends in Cardiovascular Disease: Incidence and Risk Factors

    3. Prediction of Cardiovascular Disease: Framingham Risk Estimation and Beyond

    4. Genetics of Cardiovascular Disease and Its Role in Risk Prediction

    5. Novel Biomarkers Assessing Cardiovascular Risk

    6. Advanced Risk Assessment in Patients with Kidney and Inflammatory Diseases

    7. Antiplatelet Therapy

    8. Molecular Biology and Genetics and Atherosclerosis

    9. Hypertension: JNC 7 and Beyond

    10. Heart Failure Prevention

    11. Antihypertensive Drugs and Their Cardio- and Renoprotective Roles in the Prevention and Management of Cardiovascular Disease

    12. Evaluation and Management of Dyslipidemia in Children and Adolescents

    13. The Role of HDL Cholesterol in the Development of Atherosclerotic CVD

    14. Low-Density Lipoprotein Cholesterol: Role in Atherosclerosis and Approaches to Therapeutic Management

    15. The Contribution of Triglycerides and Triglyceride-Rich Lipoproteins to Atherosclerotic Cardiovascular Disease

    16. Nutritional Approaches for CVD Prevention

    17. Integrative Medicine in the Prevention of Cardiovascular Disease

    18. Effects of Alcohol on CVD Risk

    19. Overweight, Obesity, and Cardiovascular Risk

    20. Tobacco Use, Passive Smoking, and Cardiovascular Disease: Research and Smoking Cessation Interventions

    21. Diabetes and Cardiovascular Disease

    22. Metabolic Syndrome and Cardiovascular Disease

    23. Role of Ethnicity in CVD - Lessons learned from MESA and other population based studies

    24. Prevention of Ischemic Heart Disease in Women

    25. Cardiovascular Aging the Next Frontier in Cardiovascular Prevention

    26. Concepts of Screening for Cardiovascular Risk Factors and Disease

    27. Role of Vascular CT in Evaluation and Prevention of CVD

    28. Use of Cardiac MRI and PET in Assessment of CVD Risk and Atherosclerosis Progression

    29. Exercise Treadmill Stress Testing with and without Imaging

    30. Carotid Intima-Media Thickness Measurement and Plaque Detection for

    Cardiovascular Disease Risk Prediction

    31. Peripheral Artery Disease Assessment and Management

    32. Endothelial Function and Dysfunction

    33. Exercise for Restoring Health and Preventing Vascular Disease FSGC

    34. Psychological Risk Factors and Coronary Artery Disease: Epidemiology, Pathophysiology and Management

    35. The Role of Treatment Adherence in Cardiac Risk Factor Modification

    36. Clinical Practice Guidelines and Performance Measures in the Treatment of Cardiovascular Disease

Komentarze (0)